BCAX

BCAX Market Capitalization Overview
Market Cap: $1.16B as of Oct 27, 2026
$1.16B
$114.48M (9.01%)past month
As of Oct 27, 2026, BCAX has a market capitalization of $1.16B. Over the past 30 days, its market cap has decreased by -22.29%, while in the last 12 months, it has increased by 25.46%.
Market capitalization represents the total value of Bicara Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BCAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BCAX helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Bicara Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BCAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BCAX helps investors assess the company's size and compare it with competitors for better investment decisions.
BCAX Market Cap & Key Trends
See Bicara Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in BCAX
Order type
Buy in
Order amount
Est. shares
0 shares
BCAX Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Oct 1, 2026 | $1.21B | -22.29% |
| Sep 1, 2026 | $1.55B | -8.36% |
| Aug 3, 2026 | $1.70B | -10.97% |
| Jul 1, 2026 | $1.90B | +40.20% |
| Jun 1, 2026 | $1.36B | -4.50% |
| May 1, 2026 | $1.42B | +9.22% |
| Apr 1, 2026 | $1.30B | +34.80% |
| Mar 2, 2026 | $963.62M | +4.95% |
| Feb 2, 2026 | $918.15M | +2.32% |
| Jan 2, 2026 | $897.33M | -5.48% |
BCAX End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $1.16B | +25.46% |
| 2025 | $921.99M | -2.74% |
| 2024 | $947.92M | — |
FAQs About Bicara Therapeutics Inc (BCAX) Market Cap
As of Oct 27, 2026, the market capitalization of BCAX is $1.16B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Bicara Therapeutics Inc’s market capitalization has decreased by -9.01%, changing from $1.28B to $1.16B as of Oct 27, 2026.
In the last 3 months, Bicara Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Bicara Therapeutics Inc’s market capitalization decreased from $947.92M in January to $921.99M in December, reflecting a -2.74% change.
In the past five years, BCAX has had a compound annual growth rate (CAGR) of -1.38% in market capitalization. This means its market cap has shrunk at an average rate of -1.38% per year.
BCAX Market Cap & Key Trends
See Bicara Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in BCAX
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.